L1CAM and small cell lung carcinoma: Murine and human SCLC cell lines have variable baseline expression of L1CAM, (76%, 14%, and 49% positivity; for 984, H2081 and H841 cells, respectively) and flow cytometry analysis revealed significant dose-dependent reduction in L1CAM positivity in 6TdG treated cells (Fig. 2c).